A Multicenter, Randomized, Double-Blind, Controlled Phase III Study of CPT or Placebo in Combination with Thalidomide and Dexamethasone in Subjects with Relapsed or Refractory Multiple Myeloma
Latest Information Update: 27 Nov 2023
At a glance
- Drugs Aponermin (Primary) ; Dexamethasone; Thalidomide
- Indications Multiple myeloma
- Focus Therapeutic Use
Most Recent Events
- 27 Nov 2023 New trial record